Sunflower Pharmaceuticals Group Co Ltd (002737) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.028x

Based on the latest financial reports, Sunflower Pharmaceuticals Group Co Ltd (002737) has a cash flow conversion efficiency ratio of -0.028x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-117.97 Million ≈ $-17.26 Million USD) by net assets (CN¥4.23 Billion ≈ $619.26 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 002737 market cap overview for the company's overall valuation and market capitalisation.

Sunflower Pharmaceuticals Group Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Sunflower Pharmaceuticals Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Sunflower Pharmaceuticals Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sunflower Pharmaceuticals Group Co Ltd ranked by their cash flow conversion efficiency. Explore Sunflower Pharmaceuticals Group Co Ltd (002737) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Hangzhou Jingye Intelligent Technology Co. Ltd. A SHG:688290	N/A
Emerald Expositions Events Inc NYSE:EEX	0.005x
Bank Tabungan Negara Persero JK:BBTN	-0.282x
Seneca Foods Corp A NASDAQ:SENEA	0.141x
Shantou Wanshun Package Material SHE:300057	-0.017x
Supalai Public Company Limited BK:SPALI	0.027x
Phoenix Education Partners, Inc. NYSE:PXED	0.113x
China Reform Health Management and Services Group Co Ltd SHE:000503	-0.066x

Annual Cash Flow Conversion Efficiency for Sunflower Pharmaceuticals Group Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Sunflower Pharmaceuticals Group Co Ltd from 2011 to 2025. View Sunflower Pharmaceuticals Group Co Ltd (002737) share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥3.99 Billion ≈ $583.96 Million	CN¥574.97 Million ≈ $84.14 Million	0.144x	+315.08%
2024-12-31	CN¥4.59 Billion ≈ $671.66 Million	CN¥-307.48 Million ≈ $-44.99 Million	-0.067x	-136.31%
2023-12-31	CN¥5.00 Billion ≈ $732.34 Million	CN¥923.30 Million ≈ $135.11 Million	0.184x	-58.45%
2022-12-31	CN¥4.44 Billion ≈ $649.53 Million	CN¥1.97 Billion ≈ $288.39 Million	0.444x	+101.93%
2021-12-31	CN¥3.94 Billion ≈ $575.83 Million	CN¥865.23 Million ≈ $126.61 Million	0.220x	-36.27%
2020-12-31	CN¥3.39 Billion ≈ $496.17 Million	CN¥1.17 Billion ≈ $171.19 Million	0.345x	+20.58%
2019-12-31	CN¥3.43 Billion ≈ $501.87 Million	CN¥981.33 Million ≈ $143.60 Million	0.286x	+13.53%
2018-12-31	CN¥3.44 Billion ≈ $502.93 Million	CN¥866.21 Million ≈ $126.75 Million	0.252x	+42.60%
2017-12-31	CN¥3.16 Billion ≈ $462.64 Million	CN¥558.77 Million ≈ $81.77 Million	0.177x	+45.25%
2016-12-31	CN¥2.80 Billion ≈ $410.38 Million	CN¥341.23 Million ≈ $49.93 Million	0.122x	+152.41%
2015-12-31	CN¥2.61 Billion ≈ $381.99 Million	CN¥125.84 Million ≈ $18.41 Million	0.048x	-72.75%
2014-12-31	CN¥2.28 Billion ≈ $333.59 Million	CN¥403.23 Million ≈ $59.00 Million	0.177x	-47.60%
2013-12-31	CN¥869.02 Million ≈ $127.17 Million	CN¥293.34 Million ≈ $42.93 Million	0.338x	-21.79%
2012-12-31	CN¥758.39 Million ≈ $110.98 Million	CN¥327.31 Million ≈ $47.90 Million	0.432x	-8.95%
2011-12-31	CN¥543.47 Million ≈ $79.53 Million	CN¥257.60 Million ≈ $37.70 Million	0.474x	--

About Sunflower Pharmaceuticals Group Co Ltd

SHE:002737 China Drug Manufacturers - Specialty & Generic

Market Cap

$961.40 Million

CN¥6.57 Billion CNY

Market Cap Rank

#9141 Global

#2269 in China

Share Price

CN¥11.25

Change (1 day)

+0.27%

52-Week Range

CN¥11.21 - CN¥15.62

All Time High

CN¥28.79